Clinical trials recruiting in Shaoxing, China

Phase breakdown

Conditions recruiting in Shaoxing, China

Recruiting trials in Shaoxing, China

• A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
  NCT07043725 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
  NCT07761117 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
  NCT07068438 · Phase: Not applicable (e.g. observational or device study) · Ages: 35 Years to 80 Years · Sex: All (male and female)
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Effects of Music During Atrial Fibrillation Ablation Under Conscious Sedation
  NCT06953752 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Remimazolam for Bronchoscopy in High-Risk Patients
  NCT07395596 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Shaoxing, China?

7 recruiting trials have at least one study site in Shaoxing, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.